No Detail Found!

Outcome of adult acute lymphoblastic leukemia: a single center experience.

Author(s)
M Usman The Aga Khan University Hospital, Karachi, Pakistan
I Burney Departments of Pathology and Medicine, The Aga Khan University Hospital, Karachi, Pakistan
A. Nasim Departments of Pathology and Medicine, The Aga Khan University Hospital, Karachi, Pakistan
T. Siddiqui The Aga Khan University Hospital, Karachi, Pakistan
M. Khurshid The Aga Khan University Hospital, Karachi, Pakistan
Abstract
To study the outcomes of adult patients with acute lymphoblastic leukemia. Tertiary care hospital. Retrospective analysis. Fifty-eight adult patients (age >14years) diagnosed as cases of acute lymphoblastic leukemia were studied with respect to their clinical, morphological and immunopathological features at presentation and their relationship with treatment outcomes. Forty five (77.5%) of the patients belonged to younger age group with male preponderance. The median age was 20 years and mean age was 25.1 years. Male to female ratio was 3:1. Common presenting signs were lymphadenopathy (17.2%), hepatomegaly (32.7%) and splenomegaly (62%). Laboratory features at Presentation revealed: hemoglobin ≥ 10gm/dl in 18 (31%), WBC >50 x 10E91/L in 18 (31%), LDH more than 1000 IU/L in 44 (75.8%) of patients. Morphology revealed that FAB L 1 was seen in 21 (37.2%) and L2 in 62 (32.7%). Immunophenotyping showed that 26 (61.9%) were early pre-B ALL, 6 (14.2%) were pre -B ALL and T -ALL were 10 (23.8%). Univariate analysis showed age more than 30 years, male gender, total leucocyte count >50x109/L and hemoglobin more than 10gm/dl to be risk factors for poor outcome. Multivariate analysis revealed age more than 30 years, male sex and total leucocyte count> 50 x 109/L are independent risk factors for poor survival. Patients were treated according to the MRCUKX and XII adult protocols. Thirteen (22.4%) patients died during induction therapy secondary to sepsis and progressive disease whereas 42(72.4%) patients achieved complete remission. Median survival was 18.6 months and 42% patients were alive at 5-years. Overall survival and disease free survival were comparable to those reported in literature. However, age more than 30 years, male gender and total leucocyte count >50 x 109/L had an adverse impact on overall survival.
Publication Details
Page(s) 384-387
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 53, Issue: 9, Year: 2003

Request the full text from PASTIC

0

Citations

0

Downloads

116

Views